NEXT BIOMETRICS GROUP AS (NEXT.OL) Stock Cash Flow
OSL:NEXT - Euronext Oslo - NO0010629108 - Common Stock - Currency: NOK
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -38.86M | -65.50M | -46.39M | -58.39M | -104.78M | |||
| Depreciation Amortization | 5.39M | 7.07M | 7.23M | 7.07M | 15.28M | |||
| Change In Working Capital | -30.21M | -13.53M | 4.71M | -18.00M | -1.82M | |||
| Interest Paid | N/A | 303.00K | 131.00K | N/A | N/A | |||
| Other non cash items | 1.97M | 15.66M | 2.07M | 21.65M | 10.95M | |||
| OPERATING CASH FLOW | -61.71M | -56.30M | -32.38M | -47.68M | -80.37M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -572.00K | -13.00K | -70.00K | -204.00K | -88.00K | |||
| Other Investing Activity | N/A | 0.00 | 696.00K | 693.00K | 128.00K | |||
| INVESTING CASH FLOW | -572.00K | -13.00K | 626.00K | 489.00K | 40.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -2.02M | -2.08M | -2.74M | -3.41M | 5.58M | |||
| Stock Issued/Repurchased | 62.44M | 60.15M | 747.00K | 86.68M | 55.72M | |||
| Other Financing Activity | -2.31M | -3.13M | -9.00K | 1.00K | -1.00K | |||
| FINANCING CASH FLOW | 58.11M | 54.94M | -2.00M | 83.27M | 61.30M | |||
| Exchange Rate Effect | -679.00K | -178.00K | 347.00K | -1.32M | -1.56M | |||
| CHANGE IN CASH | -4.85M | -1.55M | -33.41M | 34.76M | -20.59M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -61.71M | -56.30M | -32.38M | -47.68M | -80.37M | |||
| Capital Expenditure | -572.00K | -13.00K | -70.00K | -204.00K | -88.00K | |||
| FREE CASH FLOW | -62.28M | -56.31M | -32.45M | -47.88M | -80.46M | |||
All data in NOK